iSpecimen Inc.·4

Jan 19, 4:04 PM ET

Mullan Jill 4

4 · iSpecimen Inc. · Filed Jan 19, 2023

Insider Transaction Report

Form 4
Period: 2023-01-17
Mullan Jill
DirectorCOO & Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-17$1.00/sh+66,637$66,637246,226 total
  • Exercise/Conversion

    Option

    2023-01-1766,63710,000 total
    Exercise: $1.00Exp: 2023-01-22Common Stock (66,637 underlying)
Footnotes (4)
  • [F1]Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.
  • [F2]Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options.
  • [F3]Represents the stock options that were vested on the date of termination of employment of the Reporting Person and will expire if not exercised by the Reporting Person before January 22, 2023.
  • [F4]Represents remaining granted stock options across all grants.

Documents

1 file
  • 4
    tm233905-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT